I will discuss hurdles for the development of therapies for muscle disorders. I will present our platforms based upon iPS cells, inducible myogenesis and human artificial chromosomes. Extension of these technologies for tissue engineering and drug development will also be discussed.
Interested in seeing more content from SELECTBIO?
Discover all their latest news, webinars, products and more by clicking the link below.
